South America Ovarian Cancer Diagnostics & Therapeutics Market Size & Share Analysis - Industry Research Report

South America Ovarian Cancer Diagnostics & Therapeutics Market Size

View Global Report

Study Period	2019 - 2029
Base Year For Estimation	2023
Forecast Data Period	2024 - 2029
Historical Data Period	2019 - 2022
CAGR	9.20 %
Major Players *Disclaimer: Major Players sorted in no particular order

Compare market size and growth of South America Ovarian Cancer Diagnostics and Therapeutics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

South America Ovarian Cancer Diagnostics & Therapeutics Market Analysis

The rising incidences of ovarian cancer are one of the primary drivers for the market. The cancer burden is increasing, owing to factors such as the aging population, poor diet, smoking, and physical inactivity. According to Globocan, in 2018, there were around 243,588 deaths due to cancer in Brazil. Ovarian cancer (OC) is the most common cancer among women. OC has a high mortality rate and is difficult to diagnose. Due to its silent progression, it is contributing to the high mortality rate. Thus, due to the increasing incidence of ovarian cancer, the market for cancer diagnostics and therapeutics is expected to see stable growth in South America. Additionally, the rising geriatric population and increase in healthcare expenditure also contribute to the growth of the market.

South America Ovarian Cancer Diagnostics & Therapeutics Market Trends

This section covers the major market trends shaping the South America Ovarian Cancer Diagnostics & Therapeutics Market according to our research experts:

CT Scan Segment is Expected to Show Better Growth in the Forecast Years

Based on Diagnosis, the market is segmented into Biopsy, Blood Tests, Ultrasound, PET, CT Scan and Other Diagnosis.
Computed Tomography (CT) is an imaging procedure that uses special X-ray equipment to create detailed pictures, or scans, of areas inside the body. It is also called computerized tomography and computerized axial tomography (CAT). These equipment do not show small ovarian tumors well, but they can see larger tumors and may be able to see if the tumor is growing into nearby structures.
The use of modern CT machines with robot-assisted surgical systems is improving surgical outcomes. Hence, CT machines are the highly beneficial and preferred method of imaging for many conditions, which is expected to propel the growth of the market, over the forecast period.

South America Ovarian Cancer Diagnostics and Therapeutics Market 1

Understand The Key Trends Shaping This Market

Download PDF

South America Ovarian Cancer Diagnostics & Therapeutics Industry Overview

The market for ovarian cancer diagnostics and therapeutics market in South America is moderately competitive and consists of the global players such as AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson and Siemens AG, Furthermore, with rising technological advancements and innovation, more companies are expected to penetrate the market in the coming future.

South America Ovarian Cancer Diagnostics & Therapeutics Market Leaders

AstraZeneca plc
F. Hoffman-La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson
Siemens AG

*Disclaimer: Major Players sorted in no particular order

South America Ovarian Cancer Diagnostics and Therapeutics Market 2.png

Need More Details on Market Players and Competitors?

Download PDF

South America Ovarian Cancer Diagnostics & Therapeutics Market Report - Table of Contents

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Incidences of Ovarian Cancer
  2. 4.2.2 Rising Geriatric Population
  3. 4.2.3 Increase in Healthcare Expenditure
3. 4.3 Market Restraints
  1. 4.3.1 Lack of Awareness
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Cancer Type
  1. 5.1.1 Epithelial Ovarian Tumors
  2. 5.1.2 Ovarian Germ Cell Tumors
  3. 5.1.3 Others
2. 5.2 By Modality
  1. 5.2.1 Diagnosis
    1. 5.2.1.1 Biopsy
    2. 5.2.1.2 Blood Tests
    3. 5.2.1.3 Ultrasound
    4. 5.2.1.4 PET
    5. 5.2.1.5 CT Scan
    6. 5.2.1.6 Other Diagnosis
  2. 5.2.2 Therapeutics
    1. 5.2.2.1 Chemotherapy
    2. 5.2.2.2 Radiation Therapy
    3. 5.2.2.3 Immunotherapy
    4. 5.2.2.4 Hormonal Therapy
    5. 5.2.2.5 Others
3. 5.3 Geography
  1. 5.3.1 South America
    1. 5.3.1.1 Brazil
    2. 5.3.1.2 Argentina
    3. 5.3.1.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 AstraZeneca plc
  2. 6.1.2 Boehringer Ingelheim GmbH
  3. 6.1.3 Bristol-Myers Squibb Company
  4. 6.1.4 Eli Lilly and Company
  5. 6.1.5 F. Hoffman-La Roche Ltd
  6. 6.1.6 GlaxoSmithKline plc
  7. 6.1.7 Johnson & Johnson
  8. 6.1.8 Siemens AG
2. *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections

Get Price Break-up Now

South America Ovarian Cancer Diagnostics & Therapeutics Industry Segmentation

As per the scope of the report, Ovarian cancer is a type of cancer that begins in the ovaries. There are several types of ovarian cancer, among which Epithelial ovarian cancer is the most common type of ovarian cancer. The report covers various diagnostic and therapeutics used in the treatment of ovarian cancer.

By Cancer Type
		Epithelial Ovarian Tumors
		Ovarian Germ Cell Tumors
		Others

By Modality

Diagnosis
	Biopsy
	Blood Tests
	Ultrasound
	PET
	CT Scan
	Other Diagnosis

Therapeutics
	Chemotherapy
	Radiation Therapy
	Immunotherapy
	Hormonal Therapy
	Others

Geography

South America
	Brazil
	Argentina
	Rest of South America

Need A Different Region Or Segment?

Customize Now

South America Ovarian Cancer Diagnostics & Therapeutics Market Research FAQs

What is the current South America Ovarian Cancer Diagnostics and Therapeutics Market size?

The South America Ovarian Cancer Diagnostics and Therapeutics Market is projected to register a CAGR of 9.20% during the forecast period (2024-2029)

Who are the key players in South America Ovarian Cancer Diagnostics and Therapeutics Market?

AstraZeneca plc, F. Hoffman-La Roche Ltd, GlaxoSmithKline plc , Johnson & Johnson and Siemens AG are the major companies operating in the South America Ovarian Cancer Diagnostics and Therapeutics Market.

What years does this South America Ovarian Cancer Diagnostics and Therapeutics Market cover?

The report covers the South America Ovarian Cancer Diagnostics and Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the South America Ovarian Cancer Diagnostics and Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

South America Ovarian Cancer Diagnostics and Therapeutics Industry Report

Statistics for the 2024 South America Ovarian Cancer Diagnostics and Therapeutics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South America Ovarian Cancer Diagnostics and Therapeutics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Study Period:
CAGR:
Countries/ Region Covered:
Major Players:

South America Ovarian Cancer Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)